Literature DB >> 9756823

New drug treatment for Alzheimer's disease. Doctors want to offer more than sympathy.

T Dening, C Lawton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9756823      PMCID: PMC1113992     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  New drug treatment for Alzheimer's disease: lessons for healthcare policy.

Authors:  D Melzer
Journal:  BMJ       Date:  1998-03-07

2.  Drug treatments for Alzheimer's disease.

Authors:  C A Kelly; R J Harvey; H Cayton
Journal:  BMJ       Date:  1997-03-08

3.  Double-blind, placebo-controlled study of metrifonate, an acetylcholinesterase inhibitor, for Alzheimer disease.

Authors:  R E Becker; J A Colliver; S J Markwell; P L Moriearty; L K Unni; S Vicari
Journal:  Alzheimer Dis Assoc Disord       Date:  1996       Impact factor: 2.703

4.  Tacrine in Alzheimer's disease.

Authors:  S A Eagger; R Levy; B J Sahakian
Journal:  Lancet       Date:  1991-04-27       Impact factor: 79.321

5.  A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.

Authors:  S L Rogers; M R Farlow; R S Doody; R Mohs; L T Friedhoff
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

6.  A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.

Authors:  M Farlow; S I Gracon; L A Hershey; K W Lewis; C H Sadowsky; J Dolan-Ureno
Journal:  JAMA       Date:  1992-11-11       Impact factor: 56.272

7.  Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease.

Authors:  R Katzman; T Brown; L J Thal; P A Fuld; M Aronson; N Butters; M R Klauber; W Wiederholt; M Pay; R B Xiong
Journal:  Ann Neurol       Date:  1988-09       Impact factor: 10.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.